ESPE Abstracts

ESPE Abstracts

Published by BioScientifica
Previous issue | Volume 98 | ESPE2024

62nd Annual ESPE (ESPE 2024)

Liverpool, UK
16 Nov 2024 - 18 Nov 2024

Card image cap
The 62nd ESPE Annual Meeting will now be taking place in Liverpool, UK.

Symposia

Challenges in the management of Prader Willi Syndrome

Previous section
Novel advances in paediatric thyroid disease
Table of contents
Next section
Microbiota in type 1 diabetes

hrp0098s10.1 | Challenges in the management of Prader Willi Syndrome | ESPE2024

Abstract unavailable...
0 shares

hrp0098s10.2 | Challenges in the management of Prader Willi Syndrome | ESPE2024

Abstract unavailable...
0 shares

hrp0098s10.3 | Challenges in the management of Prader Willi Syndrome | ESPE2024

Growth hormone treatment in adults with PWS

Höybye Charlotte

Prader-Willi syndrome (PWS) is a rare, neurodevelopmental, genetic disorder in adults characterized by muscular hypotonia, a different body composition with more body fat than muscle mass, hyperphagia, behavioral challenges and cognitive dysfunction. Endocrine deficiencies, including growth hormone (GH) deficiency, are common. In many countries GH is approved for treatment of children with genetically confirmed PWS, whereas treatment of adolescents and adults is only approved ...
2 shares

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2024 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more